XML 17 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net income $ 6,287 $ 4,861
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 22,411 21,745
Amortization of right-of-use assets 1,887 1,484
Amortization of debt issuance costs 95 112
Stock-based compensation 44,910 60,394
Deferred income taxes 7,825 (5,725)
Change in fair value of other equity security 0 (302)
Unrealized foreign exchange loss 248 31
Gain on sale of assets held for sale 0 (14,337)
Gain on sale of available-for-sale debt security 0 (648)
Loss on disposal of property and equipment 15 97
Changes in operating assets and liabilities, net of effects of business combination:    
Accounts receivable 828 (14,254)
Prepaid expenses and other current assets (6,979) 3,726
Other assets 522 83
Accounts payable 8,698 4,454
Accrued expenses and other liabilities (15,566) (697)
Operating lease liabilities (1,852) (1,056)
Income tax payable 15 239
Deferred revenue 17,485 29,635
Net cash provided by operating activities 86,829 89,842
Cash flows from investing activities    
Acquisition, net of cash acquired 0 (48,468)
Proceeds from sale of assets held for sale 0 37,051
Proceeds from sale of available-for-sale debt security 0 1,507
Purchase of property and equipment (12,165) (16,908)
Net cash used in investing activities (12,165) (26,818)
Cash flows from financing activities    
Payment of deferred consideration from business acquisition (12,514) 0
Proceeds from issuance of stock under employee stock plans 518 44,657
Repayment of capital lease obligations 0 (2)
Share repurchase costs (excise tax) 0 (1,264)
Repurchase of common stock (89,010) (20,419)
Shares surrendered for settlement of minimum statutory tax withholding (9,459) (11,172)
Net cash (used in) provided by financing activities (110,465) 11,800
Effect of exchange rate changes on cash and cash equivalents (72) 147
Net (decrease) increase in cash and cash equivalents (35,873) 74,971
Cash and cash equivalents, at beginning of the period 203,100 142,064
Cash and cash equivalents, at end of the period 167,227 217,035
Non-cash operating, investing, and financing activities:    
Acquisition-related deferred consideration  101 13,058
Accrued stock repurchase excise tax 730 0
Issuance of common stock for business acquired 0 20,048
Purchase of property and equipment included in accounts payable and accrued expenses and other current liabilities 1,532 1,029
Capitalized stock-based compensation 2,570 2,920
Right-of-use assets obtained in exchange of operating lease liabilities (excluding right-of-use assets acquired as part of business acquisition) 2,623 4,059
Cash paid during the period for:    
Interest on deferred consideration for business acquisition $ 626 $ 0